Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -52,179 | -181,119 | -138,626 | -97,765 | -52,764 |
| Depreciation Amortization | 3,518 | 1,672 | 3,420 | 788 | 350 |
| Accounts receivable | -1,893 | -5,199 | -2,303 | -1,705 | N/A |
| Accounts payable and accrued liabilities | 5,167 | 1,543 | -14,169 | -1,600 | -53 |
| Other Working Capital | 2,754 | -17,410 | -19,608 | -5,128 | -5,764 |
| Other Operating Activity | 6,200 | 27,085 | 31,858 | 12,969 | 4,599 |
| Operating Cash Flow | $-36,433 | $-173,428 | $-139,428 | $-92,441 | $-53,632 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 23,031 | 32,310 | 73,086 | 112,688 | 72,649 |
| PPE Investments | -4,567 | -281 | -282 | -187 | -127 |
| Purchase Sale Intangibles | N/A | -4,000 | -4,000 | -4,000 | N/A |
| Other Investing Activity | 0 | -4,000 | -4,000 | -4,000 | 0 |
| Investing Cash Flow | $18,464 | $28,029 | $68,804 | $108,501 | $72,522 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 72,338 | 75,000 | 37,500 | N/A |
| Debt Repayment | -1,351 | N/A | 0 | N/A | N/A |
| Common Stock Issued | 1,218 | 141,490 | 121,463 | 399 | 399 |
| Financing Cash Flow | $-133 | $213,828 | $196,463 | $37,899 | $399 |
| Exchange Rate Effect | 86 | N/A | 0 | N/A | N/A |
| Beginning Cash Position | 128,005 | 59,576 | 59,576 | 59,576 | 59,576 |
| End Cash Position | 109,989 | 128,005 | 185,415 | 113,535 | 78,865 |
| Net Cash Flow | $-18,016 | $68,429 | $125,839 | $53,959 | $19,289 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,433 | -173,428 | -139,428 | -92,441 | -53,632 |
| Capital Expenditure | -4,567 | -281 | -282 | -187 | -127 |
| Free Cash Flow | -41,000 | -173,709 | -139,710 | -92,628 | -53,759 |